Hillstar Bio
Boston
About Hillstar Bio
Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $67.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2025)
- Website: hillstarbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/hillstar-bio-82360 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.